Racial differences in hepatitis C treatm
β
Michael T. Melia; Andrew J. Muir; Jonathan McCone; Mitchell L. Shiffman; John W.
π
Article
π
2011
π
John Wiley and Sons
π
English
β 258 KB
Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment with peginterferon (PEG-IFN) plus ribavirin (RBV). The impact of race on HCV treatment eligibility is unknown. We therefore performed a retrospective analysis of a phas